TSPAN13 and central nervous system cancer: While our study primarily focused on identifying TSPAN13 as a novel prognostic marker for TMZ resistance in glioma, further research is needed to determine the underlying mechanisms and regulatory pathways associated with TSPAN13 in more detail.